Evaluation and treatment of the patient coinfected with hepatitis B and HIV

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Hepatitis B virus (HBV) is a common coinfection in HIV-infected patients, and significant liver disease and mortality occur as the result of this disease combination. Potent anti-HBV therapy is available and can be used to improve outcomes by suppressing HBV DNA. Many HBV agents have dual activity with HIV and may be used to treat both diseases. However, care must be taken when using HBV nucleos(t)ides that have not been fully studied in the HIV-infected population because the emergence of strains resistant to HIV treatment has been reported. Careful monitoring of response to treatment is needed when treating an HIV/HBV patient with severe immune suppression. Improved ability to obtain long-term HBV DNA suppression and avoid resistance will translate into improved survival in this population.

Original languageEnglish (US)
Pages (from-to)103-111
Number of pages9
JournalCurrent HIV/AIDS Reports
Volume5
Issue number3
DOIs
StatePublished - Aug 1 2008

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Evaluation and treatment of the patient coinfected with hepatitis B and HIV'. Together they form a unique fingerprint.

  • Cite this